IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) was originally identified as an autoantigen in hepatocellular carcinoma but has also recently been implicated in esophageal adenocarcinoma [24]. The gene discussed is IGF2BP2; the disease is hepatocellular carcinoma.